Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.

Kim Suzanne Thomas Jonathan M BatchelorP AkramJoanne R ChalmersR H HainesG D MeakinL DuleyJ C RavenscroftAndrew Rogers Tracey H Sach Miriam SanterW TanJ WhiteM E WhittonH C WilliamsS T CheungH HamadA WrightJohn R Ingram Nick J LevellJ M R GouldingA MakrygeorgouA BewleyM OgboliJ StainforthA FergusonB LagudaS WahieR EllisJ AzadA RajasekaranV EleftheriadouA A Montgomerynull null

Published in: The British journal of dermatology (2020)

Combination treatment with home-based handheld NB-UVB plus TCS is likely to be superior to TCS alone for treatment of localized vitiligo. Combination treatment was relatively safe and well tolerated but was successful in only around one-quarter of participants.

Keyphrases

randomized controlled trial
study protocol
systematic review
combination therapy
replacement therapy
phase iii
smoking cessation
double blind
placebo controlled